Pfizer, Investors Lose Sanctions Bids In Arthritis Drugs Case
A New York magistrate judge on Tuesday rejected motions for sanctions by both Pfizer Inc. and shareholders in a securities class action over investor losses due to side effects of arthritis...To view the full article, register now.
Already a subscriber? Click here to view full article